Publications by authors named "Lenka Taylor"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

9,701,393

Total Likes

192,402

Extended Reach

9,731,822

Social Features

5
D
Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints.
Valentina O Puntmann, Dietrich Beitzke, Andreas Kammerlander, Inga Voges, Dominik D Gabbert, Lenka Taylor, Peter C Taylor

J Cardiovasc Magn Reson· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time course of CYP3A activity during and after metamizole (dipyrone) in healthy volunteers.
Mareile H Breithaupt, Evelyn Krohmer, Lenka Taylor, Eva Körner, Torsten Hoppe-Tichy

Br J Clin Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral bioavailability of microdoses and therapeutic doses of midazolam as a 2-dimensionally printed orodispersible film in healthy volunteers.
Mareile H Breithaupt, Evelyn Krohmer, Lenka Taylor, Eva Koerner, Torsten Hoppe-Tichy

Eur J Clin Pharmacol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide-An Exploratory Phase I Clinical Trial.
Felicitas Stoll, Andrea Seidel-Glätzer, Ina Burghaus, Oliver Göring, Max Sauter, Lenka Taylor

Int J Mol Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol Development.
Lydia Beck, Ruth Witt, Martina Nesper-Brock, Till Milde, Simone Hettmer, Lenka A Taylor

Clin Pharmacol Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies.
Cornelis M van Tilburg, Ruth Witt, Melanie Heiss, Kristian W Pajtler, Christoph Plass, Lenka Taylor

BMC Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia.
Cornelis M van Tilburg, Till Milde, Ruth Witt, Jonas Ecker, Thomas Hielscher, Lenka Taylor

Clin Epigenetics· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial.
Kristin Werner, Daniela Küllenberg de Gaudry, Lenka A Taylor, Tobias Keck, Clemens Unger

Lipids Health Dis· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.
Barbara C Worst, Cornelis M van Tilburg, Gnana Prakash Balasubramanian, Petra Fiesel, Ruth Witt, Lenka Taylor

Eur J Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Marine Phospholipids Extract on the Lipid Levels of Metastatic and Nonmetastatic Prostate Cancer Patients.
Daniela Küllenberg de Gaudry, Lenka A Taylor, Jessica Kluth, Tobias Hübschle, Jonas Fritzsche

Int Sch Res Notices· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best practice strategies to safeguard drug prescribing and drug administration: an anthology of expert views and opinions.
Hanna M Seidling, Marion Stützle, Torsten Hoppe-Tichy, Benoît Allenet, Pierrick Bedouch, Lenka A Taylor

Int J Clin Pharm· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysophosphatidylcholine pretreatment reduces VLA-4 and P-Selectin-mediated b16.f10 melanoma cell adhesion in vitro and inhibits metastasis-like lung invasion in vivo.
Peter Jantscheff, Martin Schlesinger, Juliane Fritzsche, Lenka A Taylor, Ralph Graeser

Mol Cancer Ther· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of practice guidelines for antifungal therapy in a surgical intensive care unit and its impact on use and costs.
Stefanie Swoboda, Christoph Lichtenstern, Michael Christoff Ober, Lenka Alexandra Taylor, Dominic Störzinger

Chemotherapy· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marine phospholipids--a promising new dietary approach to tumor-associated weight loss.
Lenka A Taylor, Lars Pletschen, Jann Arends, Clemens Unger, Ulrich Massing

Support Care Cancer· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model.
Peter Jantscheff, Vittorio Ziroli, Norbert Esser, Ralph Graeser, Jessica Kluth, Lenka A Taylor

Clin Exp Metastasis· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status.
Lenka A Taylor, Jann Arends, Arwen K Hodina, Clemens Unger, Ulrich Massing

Lipids Health Dis· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis